During the past decade, St. Mary Regional Cancer Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 10 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 5 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "St. Mary Regional Cancer Center" #1 sponsor was "Radiation Therapy Oncology Group" with 5 trials, followed by "Eastern Cooperative Oncology Group" with 3 trials sponsored, "SWOG Cancer Research Network" with 3 trials sponsored, "Alliance for Clinical Trials in Oncology" with 2 trials sponsored and "NSABP Foundation Inc" with 2 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "St. Mary Regional Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 17 trials as a collaborator, "Cancer and Leukemia Group B" with 5 trials as a collaborator, "NRG Oncology" with 4 trials as a collaborator, "North Central Cancer Treatment Group" with 3 trials as a collaborator and "NCIC Clinical Trials Group" with 2 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "St. Mary Regional Cancer Center" are "Breast Cancer" (5 trials), "Lung Cancer" (2 trials), "Prostate Cancer" (2 trials), "Stage IV Breast Cancer" (2 trials) and "Anal Cancer" (1 trials). Many other conditions were trialed in "St. Mary Regional Cancer Center" in a lesser frequency.

Most popular intervention types in "St. Mary Regional Cancer Center" are "Drug" (12 trials), "Radiation" (9 trials), "Biological" (3 trials), "Other" (3 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "cisplatin" (4 trials), "radiation therapy" (4 trials), "cetuximab" (2 trials), "fluorouracil" (2 trials) and "tamoxifen citrate" (2 trials). Other intervention names were less common.

The vast majority of trials in "St. Mary Regional Cancer Center" are 12 trials for "All" genders, 3 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "St. Mary Regional Cancer Center". undefined are not yet recruiting, undefined are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in St. Mary Regional Cancer Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in St. Mary Regional Cancer Center, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".